5-bromo-3-phenyl Salicylic Acid – 25 mg

Brand:
Cayman
CAS:
99514-99-5
Storage:
-20
UN-No:
De Minimis - 3077 / 9

The aldo-keto reductase (AKR) enzymes constitute a family of related NADPH-dependent oxidoreductases. The 1C subfamily (AKR1C) includes four human hydroxysteroid dehydrogenases (HSDs), with AKR1C1 being a 20α-HSD and the other three being 3α-HSDs. AKR1C1 metabolizes progesterone to an inactive progestin, 20α-hydroxy progesterone.{17634} In addition, AKR1C1 actions have been implicated in cancer and in the processing of neuroactive steroids involved in brain function.{17637,17636,17638,17635} 5-bromo-3-phenyl Salicyclic acid selectively inhibits AKR1C1 (Ki = 140 nM) over AKR1C2 (K1 = 1.97 µM) and AKR1C3 (Ki = 21 µM).{17245} It does not inhibit AKR1C4 at 100 µM.{17245}  

 

SKU: - Category:

Description

Selective inhibitor of aldo-keto reductase 1C1 (AKR1C1; Ki = 140 nM) versus AKR1C2 and AKR1C3 (Ki = 1.97 and 21 µM, respectively); does not inhibit AKR1C4 at 100 µM


Formal name: 5-bromo-2-hydroxy-[1,1′-biphenyl]-3-carboxylic acid

Synonyms: 

Molecular weight: 293.1

CAS: 99514-99-5

Purity: ≥98%

Formulation: A crystalline solid


Product Type|Biochemicals|Small Molecule Inhibitors||Research Area